The KDM-family inhibitor JIB-04 sensitizes AML cells to venetoclax by inducing a ferroptosis-like phenotype
Authors:
- Katharina WohlanKWKatharina Wohlan
- Dandan FanDFDandan Fan
- Anna G. GuzmanAGAnna G. Guzman
- Alexis QuezadaAQAlexis Quezada
- Hyunji ParkHPHyunji Park
- Elmira KhabushevaEKElmira Khabusheva
- Farzane SivandzadeFarzane Sivandzade
- Matthew WitherMWMatthew Wither
- Amber AlcornAAAmber Alcorn
- Tamara ThevarajahTTTamara Thevarajah
- Steven M. KornblauSKSteven M. Kornblau
- Courtney D. DiNardoCDCourtney D. DiNardo
Open Access
- 16 April 2026
- journal article
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (3)
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA201611)
- National Cancer Institute (CA183252)
- National Cancer Institute (CA265748)
- National Institutes of Health (CA125123)
- National Institutes of Health (OD036336)
- Cancer Prevention and Research Institute of Texas (CPRIT-RP240432)
This publication has 57 references indexed in Scilit:
- Ferroptosis in cancer and cancer immunotherapyCancer Communications, 2022
- Glutathione‐Bioimprinted Nanoparticles Targeting of N6‐methyladenosine FTO Demethylase as a Strategy against Leukemic Stem CellsSmall, 2022
- Bone marrow microenvironment drives AML cell OXPHOS addiction and AMPK inhibition to resist chemotherapyJournal of Leukocyte Biology, 2021
- KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemiaExperimental Hematology, 2018
- PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death SignalsCell, 2017
- The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease featuresBBA Clinical, 2017
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid LeukemiaCancer Cell, 2011
- Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemiaCancer, 2007